|
C5ORF30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.804100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.458690E-03 |
| Normal-vs-Stage2 |
3.855200E-01 |
| Normal-vs-Stage3 |
2.926600E-01 |
| Normal-vs-Stage4 |
8.843800E-02 |
| Stage1-vs-Stage2 |
3.305400E-01 |
| Stage1-vs-Stage3 |
6.320100E-03 |
| Stage1-vs-Stage4 |
2.269500E-02 |
| Stage2-vs-Stage3 |
1.449170E-01 |
| Stage2-vs-Stage4 |
5.100400E-02 |
| Stage3-vs-Stage4 |
1.259760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.173500E-02 |
| Normal-vs-AfricanAmerican |
5.135200E-01 |
| Normal-vs-Asian |
6.003600E-01 |
| Caucasian-vs-AfricanAmerican |
3.223600E-01 |
| Caucasian-vs-Asian |
2.129000E-01 |
| AfricanAmerican-vs-Asian |
4.281600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.363900E-03 |
| Normal-vs-Female |
3.889000E-01 |
| Male-vs-Female |
2.798300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.389200E-01 |
| Normal-vs-Extreme_Weight |
1.907830E-02 |
| Normal-vs-Obese |
8.096500E-02 |
| Normal-vs-Extreme_Obese |
5.479200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.416190E-01 |
| Normal_Weight-vs-Obese |
3.001600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.106200E-01 |
| Extreme_Weight-vs-Obese |
4.845000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.868400E-01 |
| Obese-vs-Extreme_Obese |
7.873200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.039800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.591000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.236700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.544430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.035700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.059900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.712300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.334400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.504200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.578800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.75450000000122E-05 |
| Normal-VS-Type2 PRCC |
2.703400E-01 |
| Normal-VS-KIRP CIMP |
1.009780E-02 |
| Normal-VS-Unclassified PRCC |
1.766390E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.20989999996546E-06 |
| Type1 PRCC-VS-KIRP CIMP |
1.403450E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.082400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.637500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.283900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.715500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.416400E-01 |
| Normal-vs-N1 |
4.532200E-02 |
| Normal-vs-N2 |
5.816200E-01 |
| N0-vs-N1 |
5.683100E-03 |
| N0-vs-N2 |
2.589600E-01 |
| N1-vs-N2 |
8.218400E-01 |
|
|
